Harbour Investments’s DNA X Inc SONM Stock Holding History

Harbour Investments’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	-$1K	–	3547
2021 Q3	$1K	Buy	+1	New	+$759	﹤0.01%	3589

Other funds holding SONM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Harbour Investments's SONM Position: Q4 2021 in Review

Harbour Investments sold out of DNA X Inc (SONM) in Q4 2021, closing a stake of 1 share — an estimated $1K sold.

Harbour Investments first reported a position in SONM in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 16 funds tracked by Wall St. Rank hold SONM as of Q4 2021.

Harbour Investments reported no remaining DNA X Inc position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 1 DNA X Inc share in Q4 2021, an estimated $1K.
Harbour Investments first reported a position in DNA X Inc in Q3 2021 and held it in 1 quarter.
Harbour Investments's DNA X Inc position peaked at $1K in Q3 2021.
16 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.